Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication

NCT06886620 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Intermittent Claudication

Interventions

DRUG: Cilostazol 200 mg
DRUG: Cilostazol 100 mg

Sponsor

Genovate Biotechnology Co., Ltd.,